Common diabetes drug tested as brain shield for aging MS patients
NCT ID NCT06463743
Summary
This study is testing if metformin, a common diabetes medication, can protect the brain from damage in older adults with multiple sclerosis (MS). It will involve 30 people aged 55-75 with stable MS, who will take either metformin or a placebo pill for 9 months. Researchers will use brain scans and other tests to see if metformin helps slow brain injury and disability progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UBMD Neurolgy
RECRUITINGBuffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.